These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2889359)

  • 21. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A; Busse R; Bassenge E
    Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain natriuretic factor. Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding.
    Song DL; Kohse KP; Murad F
    FEBS Lett; 1988 May; 232(1):125-9. PubMed ID: 2896603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of human artery, vein, and cultured smooth muscle cells to atrial and C-type natriuretic peptides.
    Zhang LM; Castresana MR; McDonald MH; Johnson JH; Newman WH
    Crit Care Med; 1996 Feb; 24(2):306-10. PubMed ID: 8605806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Halothane and the guanylate cyclase system.
    Nakamura K; Toda H; Hatano Y
    Anesthesiology; 1993 Mar; 78(3):617-8. PubMed ID: 8096127
    [No Abstract]   [Full Text] [Related]  

  • 25. New type of receptor found.
    Marx JL
    Science; 1989 Jun; 244(4909):1140-1. PubMed ID: 2567057
    [No Abstract]   [Full Text] [Related]  

  • 26. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasodilator drugs that act by stimulating guanylate cyclase in vascular smooth muscle].
    Castillo C; Hong E
    Arch Inst Cardiol Mex; 1991; 61(4):375-84. PubMed ID: 1683218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation and physiological roles of the guanylyl cyclase receptors.
    Tamura N; Chrisman TD; Garbers DL
    Endocr J; 2001 Dec; 48(6):611-34. PubMed ID: 11873860
    [No Abstract]   [Full Text] [Related]  

  • 30. Variability of response to atrial natriuretic peptide and sodium nitroprusside in cultured vascular smooth muscle cells from three blood vessels.
    Zhang LM; Castresana M; Newman WH
    Crit Care Med; 1994 Sep; 22(9):1461-4. PubMed ID: 8062570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guanylate cyclases: physiological processes mediated by cyclic GMP].
    Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M
    Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303
    [No Abstract]   [Full Text] [Related]  

  • 32. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ; Faison EP; Waldman SA; Schwartz K; Murad F; Rapoport RM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7661-4. PubMed ID: 6150486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
    Blaine EH; Seymour AA; Marsh EA; Napier MA
    Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
    Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
    J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
    Renowden S; Edwards DH; Griffith TM
    Br J Pharmacol; 1992 Jun; 106(2):348-53. PubMed ID: 1327377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cyclic-GMP in relaxations of vascular smooth muscle.
    Murad F; Rapoport RM; Fiscus R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 3():S111-8. PubMed ID: 2409383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta.
    Vesely DL; Norris JS; Walters JM; Jespersen RR; Baeyens DA
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1540-8. PubMed ID: 2825692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.